183 related articles for article (PubMed ID: 38302687)
1. Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.
Alrbyawi H; Annaji M; Fasina O; Palakurthi S; Boddu SHS; Hassan N; Tiwari AK; Suryawanshi A; Babu RJ
AAPS PharmSciTech; 2024 Feb; 25(2):28. PubMed ID: 38302687
[TBL] [Abstract][Full Text] [Related]
2. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
[TBL] [Abstract][Full Text] [Related]
3. Sustained Release Biodegradable Microneedles of Difluprednate for Delivery to Posterior Eye.
Shelley H; Annaji M; Grant M; Fasina O; Babu RJ
J Ocul Pharmacol Ther; 2022; 38(6):449-458. PubMed ID: 35167767
[No Abstract] [Full Text] [Related]
4. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.
Roy G; Garg P; Venuganti VVK
Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618
[TBL] [Abstract][Full Text] [Related]
5. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
Agarwal P; Scherer D; Günther B; Rupenthal ID
Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
[TBL] [Abstract][Full Text] [Related]
6. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye.
Wu Y; Vora LK; Mishra D; Adrianto MF; Gade S; Paredes AJ; Donnelly RF; Singh TRR
Biomater Adv; 2022 Jun; 137():212767. PubMed ID: 35929230
[TBL] [Abstract][Full Text] [Related]
7. Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment.
Hao T; Tang L; Xu Q; Wang W; Li Z; Shen Y; Xu B; Luo H; Li Q; Wang J; Zhang J
AAPS PharmSciTech; 2024 Apr; 25(5):92. PubMed ID: 38684590
[TBL] [Abstract][Full Text] [Related]
8. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A delivery to the eye: a pharmaceutical challenge.
Lallemand F; Felt-Baeyens O; Besseghir K; Behar-Cohen F; Gurny R
Eur J Pharm Biopharm; 2003 Nov; 56(3):307-18. PubMed ID: 14602172
[TBL] [Abstract][Full Text] [Related]
11. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies.
Yu Y; Chen D; Li Y; Yang W; Tu J; Shen Y
Drug Deliv; 2018 Nov; 25(1):888-899. PubMed ID: 29631468
[TBL] [Abstract][Full Text] [Related]
12. Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye.
Wu Y; Vora LK; Donnelly RF; Singh TRR
Drug Deliv Transl Res; 2023 Aug; 13(8):2142-2158. PubMed ID: 35713782
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation.
Li Y; Guan Q; Xu J; Zhang H; Liu S; Ding Z; Wang Q; Wang Z; Liu M; Zhao Y
Colloids Surf B Biointerfaces; 2023 May; 225():113267. PubMed ID: 36940502
[TBL] [Abstract][Full Text] [Related]
14. Self-assembling colloidal system for the ocular administration of cyclosporine A.
Luschmann C; Tessmar J; Schoeberl S; Strauß O; Luschmann K; Goepferich A
Cornea; 2014 Jan; 33(1):77-81. PubMed ID: 24162754
[TBL] [Abstract][Full Text] [Related]
15. Transscleral Delivery of Dexamethasone-Loaded Microparticles Using a Dissolving Microneedle Array.
Fitaihi R; Abukhamees S; Orlu M; Craig DQM
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376071
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.
Daull P; Lallemand F; Philips B; Lambert G; Buggage R; Garrigue JS
Cornea; 2013 Mar; 32(3):345-54. PubMed ID: 23023401
[TBL] [Abstract][Full Text] [Related]
17. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
Dutescu RM; Panfil C; Merkel OM; Schrage N
Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
[TBL] [Abstract][Full Text] [Related]
18. Modern approaches to the ocular delivery of cyclosporine A.
Agarwal P; Rupenthal ID
Drug Discov Today; 2016 Jun; 21(6):977-88. PubMed ID: 27080149
[TBL] [Abstract][Full Text] [Related]
19. Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections.
Albadr AA; Tekko IA; Vora LK; Ali AA; Laverty G; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2022 Apr; 12(4):931-943. PubMed ID: 34302273
[TBL] [Abstract][Full Text] [Related]
20. Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: Prolonged ocular retention, enhanced corneal permeation and improved tear production.
Liu Y; Wang Y; Yang J; Zhang H; Gan L
Int J Pharm; 2019 Jun; 565():133-142. PubMed ID: 31075435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
